Zhichao Zou

h-index10
2papers
360citations

2 Papers

4.1LGFeb 11, 2025
Treatment Effect Estimation for Exponential Family Outcomes using Neural Networks with Targeted Regularization

Jiahong Li, Zeqin Yang, Jiayi Dan et al.

Neural Networks (NNs) have became a natural choice for treatment effect estimation due to their strong approximation capabilities. Nevertheless, how to design NN-based estimators with desirable properties, such as low bias and doubly robustness, still remains a significant challenge. A common approach to address this is targeted regularization, which modifies the objective function of NNs. However, existing works on targeted regularization are limited to Gaussian-distributed outcomes, significantly restricting their applicability in real-world scenarios. In this work, we aim to bridge this blank by extending this framework to the boarder exponential family outcomes. Specifically, we first derive the von-Mises expansion of the Average Dose function of Canonical Functions (ADCF), which inspires us how to construct a doubly robust estimator with good properties. Based on this, we develop a NN-based estimator for ADCF by generalizing functional targeted regularization to exponential families, and provide the corresponding theoretical convergence rate. Extensive experimental results demonstrate the effectiveness of our proposed model.

9.2LGJun 27, 2024
Estimating Long-term Heterogeneous Dose-response Curve: Generalization Bound Leveraging Optimal Transport Weights

Zeqin Yang, Weilin Chen, Ruichu Cai et al.

Long-term treatment effect estimation is a significant but challenging problem in many applications. Existing methods rely on ideal assumptions, such as no unobserved confounders or binary treatment, to estimate long-term average treatment effects. However, in numerous real-world applications, these assumptions could be violated, and average treatment effects are insufficient for personalized decision-making. In this paper, we address a more general problem of estimating long-term Heterogeneous Dose-Response Curve (HDRC) while accounting for unobserved confounders and continuous treatment. Specifically, to remove the unobserved confounders in the long-term observational data, we introduce an optimal transport weighting framework to align the long-term observational data to an auxiliary short-term experimental data. Furthermore, to accurately predict the heterogeneous effects of continuous treatment, we establish a generalization bound on counterfactual prediction error by leveraging the reweighted distribution induced by optimal transport. Finally, we develop a long-term HDRC estimator building upon the above theoretical foundations. Extensive experiments on synthetic and semi-synthetic datasets demonstrate the effectiveness of our approach.